Discussions focused on digital health, non-communicable diseases, resilient supply chains, medical innovation, and healthcare workforce development
India’s pharmaceutical sector stands at a pivotal inflection point
Goyal reaffirmed the government’s commitment to facilitating market access, reducing trade barriers, and ensuring that Indian exporters remain globally competitive
These licenses are given in areas of infectious disease diagnostics, immunodiagnostics, and vaccine development
The three-day expo will feature an expansive exhibition showcasing MSMEs, startups, research institutions, future innovation pavilions, state showcases, and government initiatives
This year’s edition will witness participation of over 700 Indian exporters showcasing their products and services; 500+ overseas delegates representing more than 120 countries; 20,000 domestic visitors; and 8,000+ B2B meetings
A global platform advancing pharmaceutical collaboration, innovation, and exports—powering healthcare and connecting markets worldwide
India’s nutraceutical industry is expected to reach over US$ 22 billion in 2025
TB treatment coverage in India increased by 32% in the last eight years from 53% in 2015 to 85% in 2023
Nadda also commended the role of ASHA workers, “grassroot foot soldiers”, in the healthcare system
Subscribe To Our Newsletter & Stay Updated
